Aspirin antiplatelet effects are associated with body weight

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

The Lancet · 2009 · 3.7K citations · Full text

Medicine, Pharmacology, Cardiovascular Pharmacotherapy +15

Platelet Activation in Obese Women

Maria Teresa Guagnano, Giovanni Ciabattoni, Stefania Basili et al. · JAMA · 2002 · 540 citations

Medicine, Biochemistry, Nutrition +17

Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials

Peter M. Rothwell, Nancy R. Cook, J. Michael Gaziano et al. · The Lancet · 2018 · 357 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +12

The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low‐dose aspirin in patients with and without diabetes

Bianca Rocca, Francesca Santilli, Dario Pitocco et al. · Journal of Thrombosis and Haemostasis · 2012 · 249 citations · Full text

Medicine, Hematology, Pharmacology +11

Compliance as a critical consideration in patients who appear to be resistant to aspirin after healing of myocardial infarction

Kenneth A. Schwartz, Dianne E. Schwartz, Khalid Ghosheh et al. · The American Journal of Cardiology · 2005 · 210 citations

Medicine, Cardiology, Pharmacotherapy +14